Vectra Felis
ATC code
Species
Cats.
Indications
Treatment and prevention of flea infestations (Ctenocephalides felis) on cats.
One application prevents flea infestation for one month. It also prevents the multiplication of fleas by inhibiting flea emergence in the environment of the cat for 3 months.
Dose to be administered and administration route
Spot-on use.
Dosage:
The minimum recommended dose is 42.3 mg dinotefuran/kg bodyweight and 4.23 mg pyriproxyfen/kg bodyweight.
The treatment dose range is 42.3 to 705 mg dinotefuran/kg bodyweight (bw) and 4.23 to 70.5 mg pyriproxyfen/kg bodyweight (bw) for cats of 0.6 kg to 10 kg bodyweight.
Care should be taken to apply the veterinary medicinal product only onto intact (undamaged) cat’s skin.
Treatment schedule:
Following a single administration, the veterinary medicinal product will prevent flea infestation for one month and prevent further flea multiplication by inhibiting flea emergence in the environment of the cat for 3 months. The need to re-treat cats which are likely to be re-infested, and the time interval between such treatments, should be based on an assessment by a veterinarian.
How to apply:
Remove the spot-on applicator from the pack.
Step 1: Hold the applicator upright, placing fingers below the larger disk as shown.
Step 2: With the other hand, press downwards on the smaller disk until the 2 disks meet evenly. This will pierce the seal.
Step 3: The cat should be standing or in a comfortable position for easy application. At the base of cat’s head, part the hair until the skin is visible. Apply the veterinary medicinal product slowly with the tip of the applicator on the skin. Avoid superficial application to the cat’s hair.
Adverse reactions
Cats:
Rare (1 to 10 animals / 10,000 animals treated): | Scale (slight)1,2, Erythema1,2, Alopecia2 |
Very rare (<1 animal / 10,000 animals treated, including isolated reports): | Application site reaction (e.g. erythema, pruritus, lesion, inflammation, residue (white dry)1,3, hair change (wet haircoat)1,3) Hyperactivity |
Tachypnoea Muscle tremor1,4 Lethargy1,4 |
1 Transient.
2 Usually disappear spontaneously without treatment.
3 May persist up to 7 days, however, are usually not noticeable after 48 hours. These changes do not affect the safety or the efficacy of the veterinary medicinal product.
4 In particular after application site licking.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 15052/5025 |
| EAN | 3411112124787 |
